Inactive Instrument

NurExone Biologic Inc. Toronto S.E.

ENER

CA29278Q1063

Biotechnology & Medical Research

EnerSpar Corp. has Changed its Name to NurExone Biologic Inc

May 17, 2022 at 07:44 pm EDT

EnerSpar Corp. changed its name to NurExone Biologic Inc.

Latest news about NurExone Biologic Inc.

NurExone Biologic Announces OTCQB Listing And DTC Eligibility	12:48pm	MT
NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 02	CI
NurExone Biologic Building a Research and Development Facility in Israel	Mar. 08	MT
NurExone Biologic Inc. Establishes Research and Development Facility in Haifa, Israel	Mar. 08	CI
NurExone Biologic Inc. Expands Intellectual Property Portfolio	Feb. 20	CI
NurExone Launches Licensing Efforts For ExoTherapy Platform	Feb. 14	MT
NurExone Biologic Inc. Launches Licensing Efforts for ExoTherapy Platform	Feb. 14	CI
NurExone Biologic Provides Operations Update	23-07-20	MT
NurExone Biologic Posts Q1 Net Loss	23-05-24	MT
NurExone Granted U.S. Patent for Technology and Drug Composition of Exo-PTEN, For Acute Spinal Cord Injuries Treatmenet	23-05-16	MT

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ExoTherapy production platform and products for a global market. It is involved in the development of ExoPTEN, the first ExoTherapy-based product for acute Spinal Cord Injuries (SCI). The Company is developing treatment for the reversal or reduction of paralysis following spinal cord injury (SCI) using Exosomes (membrane-bound extracellular vesicles). This technology, subject to conducting clinical trials and receiving Food and Drug Administration (the FDA) approval, can be used in various conditions such as SCI, Brain Trauma Injury (BTI), and potentially other brain and neurological indications.

Sector

Biotechnology & Medical Research

Calendar

2024-05-21 - Q1 2024 Earnings Release (Projected)

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.12%	43.84B
MODERNA, INC.	+6.77%	41.68B
LONZA GROUP AG	+45.26%	41.25B
CELLTRION, INC.	-11.96%	27.04B
ICON PUBLIC LIMITED COMPANY	+6.01%	25.53B
ALNYLAM PHARMACEUTICALS, INC.	-24.92%	18.18B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.63%	12.29B
MEDPACE HOLDINGS, INC.	+27.16%	12.29B
UNITED THERAPEUTICS CORPORATION	+7.30%	11.15B

Other Biotechnology & Medical Research

NurExone Biologic Inc. Toronto S.E.

Equities

ENER

CA29278Q1063

Biotechnology & Medical Research

EnerSpar Corp. has Changed its Name to NurExone Biologic Inc

Latest news about NurExone Biologic Inc.

Chart NurExone Biologic Inc.

Company Profile

Sector Other Biotechnology & Medical Research